Good morning :)
Place Order
Add to Watchlist
Home
Portfolio
Search
GoldGold
More

Vivanta Industries Ltd

VIVANTA

Vivanta Industries Ltd

VIVANTA
Health CarePharmaceuticals
SmallcapWith a market cap of ₹50 cr, stock is ranked 3,334
High RiskStock is 3.95x as volatile as Nifty
4.080.99% (+0.04)
4.080.99% (+0.04)

Price Chart

High
—
Low
—
Returns
—
1D
1W
1M
1Y
5Y
Max
SIP
Loading...
1D
1W
1M
1Y
5Y
Max
SIP
Health CarePharmaceuticals
SmallcapWith a market cap of ₹50 cr, stock is ranked 3,334
High RiskStock is 3.95x as volatile as Nifty
Scorecard

Performance

Avg

Price return has been average, nothing exciting

Valuation

High

Seems to be overvalued vs the market average

Growth

Avg

Financials growth has been moderate for a few years

Profitability

High

Showing good signs of profitability & efficiency

Entry point

Avg

The stock is not in the overbought zone

Red flags

Low

No red flag found

How to use scorecard? Learn more

Health CarePharmaceuticals
SmallcapWith a market cap of ₹50 cr, stock is ranked 3,334
High RiskStock is 3.95x as volatile as Nifty

Key Metrics

No LabelNo LabelPB RatioPB RatioDividend YieldDiv. Yield
60.123.16—
Sector PESector PESector PBSector PBSector Div YldSctr Div Yld
46.016.090.55%

Forecast & Ratings

Detailed Forecast 
—
Forecast data is currently unavailable for this stock

Price

Price Upside

Earnings

Earnings Growth

Revenue

Rev. Growth

See Detailed Forecast

Company Profile

Vivanta Industries is engaged in trading of pharmaceutical products.

Peers

Compare with peers 
Compare with Peers

Get more out of Tickertape, Go Pro!

Customise key metrics, see detailed forecasts, download stock data and more

Forecasts

Price

Revenue

Earnings

Price Forecast

Hmm, looks like data is unavailable here. Please come back after some time

Revenue Forecast

Hmm, looks like data is unavailable here. Please come back after some time

Earnings Per Share Forecast

Hmm, looks like data is unavailable here. Please come back after some time

Income

Balance Sheet

Cash Flow

Income Statement

Industry refers to the sub-sector this company belongs to.

Higher than Industry Revenue Growth

A higher-than-industry revenue growth represents increased potential for the company to increase their market share

Over the last 5 years, revenue has grown at a yearly rate of 76.31%, vs industry avg of 8.96%

Increasing Market Share

Market share is the percentage of an industry's total sales going to a particular company. It gives a general idea of the size of a company v/s its competitors

Over the last 5 years, market share increased from 0% to 0.01%

Higher than Industry Net Income

Net income is equal to net earnings (profit) less expenses. This number is an important measure of how profitable the company is

Over the last 5 years, net income has grown at a yearly rate of 50.61%, vs industry avg of 15.15%

Loading...

Financial YearFY 2016FY 2017FY 2018FY 2019FY 2020FY 2021FY 2022FY 2023FY 2024TTM
Total Revenue0.000.220.592.190.010.541.9124.8237.3126.70
Raw Materialssubtract0.000.000.001.050.370.001.1522.5735.7925.18
Power & Fuel Costsubtract0.000.000.000.000.000.00
Employee Costsubtract0.210.140.200.330.290.16
Selling & Administrative Expensessubtract0.010.260.730.140.070.10
Operating & Other expensessubtract0.210.020.010.040.070.03
Depreciation/Amortizationsubtract0.000.060.060.050.040.190.180.160.190.26
Interest & Other Itemssubtract0.000.010.010.010.000.010.010.010.030.05
Taxes & Other Itemssubtract0.000.000.030.02-0.010.010.000.490.370.37
EPS0.00-0.040.010.02-0.03-0.030.010.080.070.05
DPS0.000.000.000.00—0.000.000.020.000.03
Payout ratio—0.000.000.000.000.000.000.230.000.56
See Costs

EPS and DPS in ₹. Other numbers except Payout Ratio in ₹ cr

Company Updates

Annual Report and Investor Presentation updates mentioned here are as reported by the company to the exchange
FY 2019

Annual report

PDF
FY 2020

Annual report

PDF
FY 2021

Annual report

PDF
FY 2022

Annual report

PDF
FY 2023

Annual report

PDF
 

Peers & Comparison

Comparing 3 stocks from 
Health CarePharmaceuticals

Valuation

Technical

Forecast

ScreenerCompare valuation on Screener

Loading...

StockPE RatioPE RatioPB RatioPB RatioDiv. YieldDividend Yield
Vivanta Industries Ltd54.303.16—
Sun Pharmaceutical Industries Ltd41.745.960.81%
Zydus Lifesciences Ltd31.445.490.25%
Cipla Ltd29.395.110.87%

Price Comparison

Compare VIVANTA with any stock or ETF
Compare VIVANTA with any stock or ETF
VIVANTA
Loading...

Shareholdings

Promoter Holdings Trend

Decreased Total Promoter Holding

Increasing promoter holding is considered good and reflects management’s positive view about the future outlook

In last 6 months, promoter holding in the company has decreased by 1.05%

Low Pledged Promoter Holding

Lower pledged promoter holdings is considered better

Pledged promoter holdings is insignificant

Institutional Holdings Trend

Increased Total Retail Holding

Increasing retail holding can be considered bad as it can reflect that institutions and promoters are selling their stake which is being absorbed by retail investors.

In last 3 months, retail holding in the company has increased by 1.75%

Foreign Institutional Holding

Foreign Institutional Holding is quantum of stock held by foreign large-quantities-trading entities. Increasing value indicates growing support and comfort for the stock

In last 3 months, foreign institutional holding of the company has almost stayed constant

Tickertape Separator

Shareholding Pattern

Retail and OthersForeign InstitutionsOther Domestic InstitutionsMutual FundsTotal Promoter Holding10.93%0.00%0.00%0.00%89.07%

Sep 2023

Dec 2023

Mar 2024

Jun 2024

Shareholding History

MarJunSepDec '23MarJun0.00%0.00%0.00%0.00%0.00%0.00%

Insider Trades & Bulk Deals

Loading...

smallcases

Looks like this stock is not in any smallcase yet.

Events

Dividend Trend

No dividend trend available

Dividends

Corp. Actions

Announcements

Legal Orders

Upcoming Dividends

No upcoming dividends are available

Past Dividends

Cash Dividend

Ex DateEx DateSep 5, 2023

Final
Final | Div/Share: ₹0.03

Dividend/Share

₹0.03

Ex DateEx Date

Sep 5, 2023

News & Opinions
Corporate
Vivanta Industries to convene AGM

Vivanta Industries announced that the 11th Annual General Meeting (AGM) of the company will be held on 22 August 2024.Powered by Capital Market - Live

15 hours agoCapital Market - Live

Vivanta Industries consolidated net profit declines 21.21% in the June 2024 quarter

22 hours agoBusiness Standard
Earnings
Vivanta Industries consolidated net profit declines 21.21% in the June 2024 quarter

Net profit of Vivanta Industries declined 21.21% to Rs 0.26 crore in the quarter ended June 2024 as against Rs 0.33 crore during the previous quarter ended June 2023. Sales declined 78.76% to Rs 2.99 crore in the quarter ended June 2024 as against Rs 14.08 crore during the previous quarter ended June 2023. ParticularsQuarter EndedJun. 2024Jun. 2023% Var. Sales2.9914.08 -79 OPM %-4.012.56 - PBDT0.350.36 -3 PBT0.260.33 -21 NP0.260.33 -21 Powered by Capital Market - Live

1 day agoCapital Market - Live

Q1 results today: Nestle, Tech Mahindra among 76 companies to announce earnings on Thursday

1 day agoEconomic Times
Corporate
Vivanta Industries to convene board meeting

Vivanta Industries will hold a meeting of the Board of Directors of the Company on 25 July 2024.Powered by Capital Market - Live

4 days agoCapital Market - Live

Vivanta Industries To Announce 1 Bonus Share And 3% Dividend For Investors - News18

11 months agoNews18

Stock with low P/E declares stock split, scrip hit 5% lower circuit

1 year agoLivemint

Board of Vivanta Industries approves stock split

1 year agoBusiness Standard

Vivanta Industries reports consolidated net profit of Rs 1.00 crore in the December 2022 quarter

1 year agoBusiness Standard

Penny stock is 89% above the 52-week-low, Board to mull stock split soon

1 year agoLivemint